Identification and analysis of compensatory mutations that support the evolution of antibiotic resistance in Neisseria gonorrhoeae
支持淋病奈瑟菌抗生素耐药性进化的补偿突变的鉴定和分析
基本信息
- 批准号:10650744
- 负责人:
- 金额:$ 72.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-17 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:Active SitesAddressAllelesAnabolismAnimal ModelAnimalsAntibiotic ResistanceAntibiotic TherapyAntibiotic susceptibilityAntibioticsBackBindingBiochemicalBiologyCeftriaxoneCell physiologyCiprofloxacinClinicalCoculture TechniquesCollectionCompensationDataDependenceDiagnosisDiagnosticDiseaseDrug resistanceEssential GenesEvolutionExclusionFemaleGenesGeneticGenetic EpistasisGenomeGenomicsGoalsGonorrheaGrowthGuidelinesHumanIn VitroInfectionKnowledgeLethal GenesLinkMaintenanceMediatingMethodsModelingMolecularMorphologyMusMutateMutationNeisseria gonorrhoeaeOrganismPathogenesisPathway interactionsPhenotypePhylogenyPhysiologicalPhysiologyPopulationPredispositionPreventionPublic HealthResearch PersonnelResistanceTestingThiamineVaccinesVariantbacterial fitnesscandidate identificationclinically relevantco-infectioncostdrug-resistant gonorrheaexperimental analysisfitnessgenome sequencingimprovedin vivoinfection rateinsightlarge datasetsmetabolomicsmouse modelmutantnovel strategiesquinolone resistancereproductive tractresistance alleleresistance mutationresistant strainsuccesssurveillance strategytranscriptomicswhole genome
项目摘要
PROJECT SUMMARY
The increasing rate of infection and spread of antibiotic resistance in Neisseria gonorrhoeae poses an urgent
threat to public health. Knowledge of the pathways and genes that support the emergence and spread of antibi-
otic resistance is necessary to develop new strategies for surveillance, diagnosis, and treatment. Despite our
understanding of the genes and alleles that confer resistance, significant knowledge gaps remain regarding the
factors that contribute to the uneven distribution of resistance across the gonococcal species phylogeny. A core
issue that remains poorly explored is the impact of resistance determinants on gonococcal fitness: to what extent
do resistance determinants impact fitness, and, if they incur a fitness cost, how does the gonococcus adapt and
mitigate these costs? In this proposal, we address these gaps through a comprehensive strategy linking experi-
mental and computational identification of compensatory mutations with studies of their mechanisms of action.
The overall goal of this project is to determine the impact of mutations that increase resistance to the two
most clinically relevant antibiotics for treatment of gonorrhea, ciprofloxacin and ceftriaxone, on bacterial fitness.
We will achieve this goal through three specific aims. In Aim 1, we will determine the fitness costs of resistance
alleles when transformed into susceptible isolates from different niches and with distinct phylogeny and identify
compensatory mutations that mitigate these fitness costs through experimental evolution in the female mouse
model. We will examine the two most common ciprofloxacin resistance-conferring alleles (gyrAS91F,D95G and
parCS87R) in clinical isolates, and four ceftriaxone resistance-conferring alleles (two variants of penA, the lethal
target of ceftriaxone, and newly described variants in rpoB and rpoD), and evaluate the dependence of compen-
satory pathways on genomic background. In Aim 2, we will leverage our collection of over 7500 gonococcal
genomes from clinical isolates for which we have antibiotic-resistance phenotypes and employ population ge-
nomics methods to identify potential compensatory mutations and test these in the mouse model. Moreover, we
will define the allelic diversity and distribution of candidates identified in Aim 1. In Aim 3, we will determine the
mechanism of action of confirmed compensatory mutations arising from the studies in Aims 1 & 2 using an
integrative strategy that examines growth and morphology, transcriptomics, metabolomics, and directed studies
of biochemical function. We will also build on preliminary data on compensatory mutations in acnB and mleN for
ceftriaxone resistance and on the thiamine biosynthesis pathway in gyrA-mediated quinolone resistance.
This interdisciplinary project brings together the complementary and non-overlapping expertise of three lead-
ing investigators in the biology and genetics of antibiotic resistance in N. gonorrhoeae, linking the mouse model
of gonococcal infection (Dr. Jerse), population genomics (Dr. Grad), and biochemical and physiological charac-
terization of resistance-related variants (Dr. Nicholas).
项目摘要
淋病奈瑟菌感染率的增加和抗生素耐药性的传播迫切需要
对公众健康的威胁。支持抗生素出现和传播的途径和基因的知识,
耳耐药性是发展新的监测、诊断和治疗策略所必需的。尽管我们
尽管对赋予抗性的基因和等位基因的了解,但有关耐药性的知识仍存在巨大差距
导致淋球菌种属间耐药性分布不均匀的因素。核心
一个尚未充分探讨的问题是耐药决定因素对淋球菌适应性的影响:在多大程度上
抗性决定因素是否影响适应性,如果它们产生适应性成本,淋球菌如何适应,
降低这些成本?在这一建议中,我们通过一项将经验和能力结合起来的全面战略来解决这些差距,
补偿突变的心理和计算识别及其作用机制的研究。
该项目的总体目标是确定增加对这两种药物耐药性的突变的影响。
大多数临床相关的抗生素治疗淋病,环丙沙星和头孢曲松,对细菌的健身。
我们将通过三个具体目标实现这一目标。在目标1中,我们将确定抵抗的适应性成本
等位基因转化到不同生态位的感病菌株中时,
通过雌性小鼠的实验进化来减轻这些适应性成本的补偿性突变
模型我们将检测两种最常见的环丙沙星耐药等位基因(gyrAS 91 F,D95 G和
parCS 87 R)和4个头孢曲松耐药等位基因(佩纳的两种变体,致死性p53基因,
头孢曲松的靶点,以及新描述的rpoB和rpoD变体),并评估compen的依赖性。
在基因组背景上的饱和途径。在目标2中,我们将利用我们收集的7500多种淋球菌,
基因组从临床分离,我们有抗药性表型,并采用人口ge-
组学方法来识别潜在的补偿突变,并在小鼠模型中测试这些突变。而且我们
将定义目标1中确定的候选者的等位基因多样性和分布。在目标3中,我们将确定
目的1和2研究中确认的补偿性突变的作用机制,
研究生长和形态学、转录组学、代谢组学和定向研究的综合策略
生物化学功能。我们还将建立在acnB和mleN补偿突变的初步数据基础上,
头孢曲松耐药性和gyrA介导的喹诺酮耐药性中的硫胺素生物合成途径。
这个跨学科项目汇集了三个领导的互补和非重叠的专业知识,
在N.淋病,连接小鼠模型,
淋球菌感染(Jerse博士),人口基因组学(格拉德博士),以及生化和生理特征,
耐药相关变异的化(Nicholas博士)。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Disseminated Gonococcal Infection Complicated by Prosthetic Joint Infection: Case Report and Genomic and Phylogenetic Analysis.
- DOI:10.1093/ofid/ofaa632
- 发表时间:2021-03
- 期刊:
- 影响因子:4.2
- 作者:Ogbebor O;Mortimer TD;Fryling K;Zhang JJ;Bhanot N;Grad YH
- 通讯作者:Grad YH
Estimating changes in antibiotic consumption in the USA with the introduction of doxycycline post-exposure prophylaxis.
随着强力霉素暴露后预防的引入,估计美国抗生素消耗量的变化。
- DOI:10.1016/s2666-5247(23)00314-2
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Roster,KirstinIOliveira;Grad,YonatanH
- 通讯作者:Grad,YonatanH
Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study.
淋病的奈瑟氏菌诊断从基于GYRA的环丙沙星易感性以及对Zoliflodacin耐药的影响的逃脱:一种细菌遗传学和实验进化研究。
- DOI:10.1016/s2666-5247(22)00356-1
- 发表时间:2023-04
- 期刊:
- 影响因子:38.2
- 作者:Rubin, Daniel H. F.;Mortimer, Tatum;Grad, Yonatan H.
- 通讯作者:Grad, Yonatan H.
Estimating changes in antibiotic consumption with the introduction of doxycycline post-exposure prophylaxis in the United States.
估计美国引入强力霉素暴露后预防后抗生素消耗量的变化。
- DOI:10.1101/2023.09.20.23295787
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Roster,KirstinIOliveira;Grad,YonatanH
- 通讯作者:Grad,YonatanH
Loci for prediction of penicillin and tetracycline susceptibility in Neisseria gonorrhoeae: a genome-wide association study.
- DOI:10.1016/s2666-5247(22)00034-9
- 发表时间:2022-05
- 期刊:
- 影响因子:38.2
- 作者:Mortimer, Tatum D.;Zhang, Jessica J.;Ma, Kevin C.;Grad, Yonatan H.
- 通讯作者:Grad, Yonatan H.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yonatan H Grad其他文献
emNeisseria gonorrhoeae/em diagnostic escape from a emgyrA/em-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study
淋病奈瑟菌对基于 gyrA 的环丙沙星敏感性检测的诊断逃逸及对唑立复林耐药性的影响:一项细菌遗传学和实验进化研究
- DOI:
10.1016/s2666-5247(22)00356-1 - 发表时间:
2023-04-01 - 期刊:
- 影响因子:20.400
- 作者:
Daniel HF Rubin;Tatum D Mortimer;Yonatan H Grad - 通讯作者:
Yonatan H Grad
Modelling molecular and culture-based surveillance of tetracycline resistance in emNeisseria gonorrhoeae/em
淋病奈瑟菌四环素耐药性基于分子和培养的监测模型
- DOI:
10.1016/s1473-3099(24)00408-0 - 发表时间:
2024-08-01 - 期刊:
- 影响因子:31.000
- 作者:
Kirstin I Oliveira Roster;Rachel Mittelstaedt;Jordan Reyes;Aishani V Aatresh;Yonatan H Grad - 通讯作者:
Yonatan H Grad
Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007–22)
美国退伍军人事务医疗保健系统感染发生率和抗菌药物耐药性趋势:一项全国性回顾性队列研究(2007-22 年)
- DOI:
10.1016/s1473-3099(24)00416-x - 发表时间:
2024-12-01 - 期刊:
- 影响因子:31.000
- 作者:
Thi Mui Pham;Yue Zhang;McKenna Nevers;Haojia Li;Karim Khader;Yonatan H Grad;Marc Lipsitch;Matthew Samore - 通讯作者:
Matthew Samore
Biodiversity and hypervirulence of Listeria monocytogenes
单核细胞增生李斯特菌的生物多样性和超强毒性
- DOI:
10.1038/ng.3515 - 发表时间:
2016-02-24 - 期刊:
- 影响因子:29.000
- 作者:
Yonatan H Grad;Sarah M Fortune - 通讯作者:
Sarah M Fortune
Yonatan H Grad的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yonatan H Grad', 18)}}的其他基金
Genetic modulators of serum resistance in Neisseria gonorrhoeae
淋病奈瑟菌血清抗性的遗传调节剂
- 批准号:
10608700 - 财政年份:2023
- 资助金额:
$ 72.33万 - 项目类别:
Identification and analysis of compensatory mutations that support the evolution of antibiotic resistance in Neisseria gonorrhoeae
支持淋病奈瑟菌抗生素耐药性进化的补偿突变的鉴定和分析
- 批准号:
10443593 - 财政年份:2020
- 资助金额:
$ 72.33万 - 项目类别:
Identification and analysis of compensatory mutations that support the evolution of antibiotic resistance in Neisseria gonorrhoeae
支持淋病奈瑟菌抗生素耐药性进化的补偿突变的鉴定和分析
- 批准号:
10034093 - 财政年份:2020
- 资助金额:
$ 72.33万 - 项目类别:
Identification and analysis of compensatory mutations that support the evolution of antibiotic resistance in Neisseria gonorrhoeae
支持淋病奈瑟菌抗生素耐药性进化的补偿突变的鉴定和分析
- 批准号:
10219082 - 财政年份:2020
- 资助金额:
$ 72.33万 - 项目类别:
Genomics approaches to elucidating pathways to antibiotic resistance in Neisseria gonorrhoeae
阐明淋病奈瑟菌抗生素耐药性途径的基因组学方法
- 批准号:
10736734 - 财政年份:2017
- 资助金额:
$ 72.33万 - 项目类别:
Genomics approaches to elucidating pathways to antibiotic resistance in Neisseria gonorrhoeae
阐明淋病奈瑟菌抗生素耐药性途径的基因组学方法
- 批准号:
9367004 - 财政年份:2017
- 资助金额:
$ 72.33万 - 项目类别:
Genomics approaches to elucidating pathways to antibiotic resistance in Neisseria gonorrhoeae
阐明淋病奈瑟菌抗生素耐药性途径的基因组学方法
- 批准号:
10190792 - 财政年份:2017
- 资助金额:
$ 72.33万 - 项目类别:
Genomic epidemiology of Neisseria gonorrhoeae with elevated MICs to cefixime
头孢克肟 MIC 升高的淋病奈瑟菌的基因组流行病学
- 批准号:
8862369 - 财政年份:2013
- 资助金额:
$ 72.33万 - 项目类别:
Genomic epidemiology of Neisseria gonorrhoeae with elevated MICs to cefixime
头孢克肟 MIC 升高的淋病奈瑟菌的基因组流行病学
- 批准号:
9005937 - 财政年份:2013
- 资助金额:
$ 72.33万 - 项目类别:
Genomic epidemiology of Neisseria gonorrhoeae with elevated MICs to cefixime
头孢克肟 MIC 升高的淋病奈瑟菌的基因组流行病学
- 批准号:
8487485 - 财政年份:2013
- 资助金额:
$ 72.33万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 72.33万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 72.33万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 72.33万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 72.33万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 72.33万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 72.33万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 72.33万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 72.33万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 72.33万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 72.33万 - 项目类别:
Research Grant